The salicylate drug Salsalate has been shown to significantly reduce several inflammatory markers including IL-6 and TNFα [32–35], and ameliorate mechanisms involved in atherosclerosis in vitro [36]. The gene discussed is IL6; the disease is atherosclerosis.